Investors in shares of Myriad Genetics, Inc. (MYGN) need to pay close attention to the stock based on moves in the options market lately. That is because the Callwhich expires onFeb 17, 2017 for the $47strike price had …
Volatility
Investors in Myriad Genetics, Inc. (Symbol: MYGN) saw new options become available today, for the April 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MYGN options …
Myriad Genetics (NASDAQ:MYGN) had its price target upped to $15.00 by Deutsche Bank in an issued report …
NASDAQ
Myriad Genetics’ competitor Invitae has started to receive lower-than-requested payments from CMS for its hereditary breast cancer-related disorders Myriad Genetics, Inc. (NASDAQ:MYGN) stock tank as low as …
Myriad Genetics, Inc. (NASDAQ:MYGN)‘s stock had its “sell” rating restated by equities researchers at Deutsche Bank AG in a note issued to investors on Wednesday. They currently have a $15.00 price objective on the …
Thecer1mon
Deutsche Bank
Large percentage drops always require that the stock post even larger percentage gains from the low in order to recover the old price point, and for MYGN that means the stock would have to gain 158.51% to get back to the …
Insider
Myriad Genetics, Inc. (NASDAQ:MYGN)’s stock has been of interest for both individual investors and Wall …
NASDAQ
Shell Asset Management Co. cut its stake in shares of Myriad Genetics Inc. (NASDAQ:MYGN) by 4.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 44,087 shares of the …
Asset management
Myriad Genetics, Inc. (MYGN) down -9.35 per cent in the past week, is under coverage of 18 analysts who collectively recommend a hold rating on stock. 8 of the analysts have a buy or better rating; the 7 sells versus …